Annual CFO
-$4.87 M
+$6.60 M+57.53%
01 December 2023
Summary:
Dogwood Therapeutics annual cash flow from operations is currently -$4.87 million, with the most recent change of +$6.60 million (+57.53%) on 01 December 2023. During the last 3 years, it has risen by +$10.82 million (+68.96%).DWTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$910.10 K
-$98.40 K-12.12%
01 September 2024
Summary:
Dogwood Therapeutics quarterly cash flow from operations is currently -$910.10 thousand, with the most recent change of -$98.40 thousand (-12.12%) on 01 September 2024. Over the past year, it has increased by +$559.10 thousand (+38.05%).DWTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$4.13 M
+$50.40 K+1.21%
01 September 2024
Summary:
Dogwood Therapeutics TTM cash flow from operations is currently -$4.13 million, with the most recent change of +$50.40 thousand (+1.21%) on 01 September 2024. Over the past year, it has increased by +$742.20 thousand (+15.24%).DWTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DWTX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +38.0% | +15.2% |
| 3 y3 years | +69.0% | +82.4% | +73.7% |
| 5 y5 years | -132.8% | - | - |
DWTX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | +307.2% | +228.1% | +1388.2% |
Dogwood Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$910.10 K(+12.1%) | -$4.13 M(-1.2%) |
| June 2024 | - | -$811.70 K(-13.4%) | -$4.18 M(+1.7%) |
| Mar 2024 | - | -$937.40 K(-36.2%) | -$4.11 M(-15.6%) |
| Dec 2023 | -$4.87 M(-57.5%) | -$1.47 M(+53.0%) | -$4.87 M(-19.8%) |
| Sept 2023 | - | -$960.50 K(+29.4%) | -$6.07 M(-20.0%) |
| June 2023 | - | -$742.40 K(-56.3%) | -$7.60 M(-27.7%) |
| Mar 2023 | - | -$1.70 M(-36.4%) | -$10.51 M(-8.3%) |
| Dec 2022 | -$11.47 M | -$2.67 M(+7.6%) | -$11.47 M(-17.9%) |
| Sept 2022 | - | -$2.48 M(-32.1%) | -$13.97 M(-1.2%) |
| June 2022 | - | -$3.66 M(+37.7%) | -$14.14 M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.66 M(-48.7%) | -$13.23 M(-15.7%) |
| Dec 2021 | -$15.69 M(+302.8%) | -$5.18 M(+95.5%) | -$15.69 M(+22.6%) |
| Sept 2021 | - | -$2.65 M(-3.7%) | -$12.80 M(+19.5%) |
| June 2021 | - | -$2.75 M(-46.2%) | -$10.71 M(+22.7%) |
| Mar 2021 | - | -$5.11 M(+123.6%) | -$8.73 M(+124.1%) |
| Dec 2020 | -$3.90 M(+86.2%) | -$2.29 M(+309.1%) | -$3.90 M(+142.1%) |
| Sept 2020 | - | -$558.90 K(-27.7%) | -$1.61 M(+53.2%) |
| June 2020 | - | -$772.60 K(+178.5%) | -$1.05 M(+278.5%) |
| Mar 2020 | - | -$277.40 K | -$277.40 K |
| Dec 2019 | -$2.09 M(+74.9%) | - | - |
| Dec 2018 | -$1.20 M | - | - |
FAQ
- What is Dogwood Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Dogwood Therapeutics?
- What is Dogwood Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Dogwood Therapeutics?
- What is Dogwood Therapeutics quarterly CFO year-on-year change?
- What is Dogwood Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Dogwood Therapeutics?
- What is Dogwood Therapeutics TTM CFO year-on-year change?
What is Dogwood Therapeutics annual cash flow from operations?
The current annual CFO of DWTX is -$4.87 M
What is the all time high annual CFO for Dogwood Therapeutics?
Dogwood Therapeutics all-time high annual cash flow from operations is -$1.20 M
What is Dogwood Therapeutics quarterly cash flow from operations?
The current quarterly CFO of DWTX is -$910.10 K
What is the all time high quarterly CFO for Dogwood Therapeutics?
Dogwood Therapeutics all-time high quarterly cash flow from operations is -$277.40 K
What is Dogwood Therapeutics quarterly CFO year-on-year change?
Over the past year, DWTX quarterly cash flow from operations has changed by +$559.10 K (+38.05%)
What is Dogwood Therapeutics TTM cash flow from operations?
The current TTM CFO of DWTX is -$4.13 M
What is the all time high TTM CFO for Dogwood Therapeutics?
Dogwood Therapeutics all-time high TTM cash flow from operations is -$277.40 K
What is Dogwood Therapeutics TTM CFO year-on-year change?
Over the past year, DWTX TTM cash flow from operations has changed by +$742.20 K (+15.24%)